Evidence map›Paper›PMID 41294147›Full record

ArticleJournal of the American Heart Association2026

Vascular and Neural Transcriptomics Reveal Stage-Dependent Pathways to Inflammation and Cognitive Dysfunction in a Rat Model of Hypertension.

Philipp Arndt, Lorena Morton, Michael Briese, Naomi Lämmlin, Hendrik Mattern, Md Hasanuzzaman, Melina Westhues, Mahsima Khoshneviszadeh, Silke Appenzeller, Daniel Gündel and 16 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Hypertensive Brain Injury as a Journey Not a Destination.Journal of the American Heart Association · 2026
    Article
  2. Unmasking the Hidden Burden: Inflammation and Cardiovascular DiseaseJournal of the American Heart Association · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Philipp Arndt *Department of Neurology Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0002-0517-6473
Lorena Morton *Institute of Inflammation and Neurodegeneration Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0002-3957-3848
Michael BrieseInstitute of Clinical Neurobiology University Hospital Würzburg Würzburg Germany.ORCID 0000-0001-7137-8260
Naomi LämmlinDepartment of Neurology University Hospital Leipzig Leipzig Germany.ORCID 0009-0003-2096-4640
Hendrik MatternGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association Magdeburg Germany.ORCID 0000-0001-5740-4522
Md HasanuzzamanDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.
Melina WesthuesDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.
Mahsima KhoshneviszadehDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.
Silke AppenzellerComprehensive Cancer Center Mainfranken University Hospital Würzburg Würzburg Germany.ORCID 0000-0002-5472-8692
Daniel GündelHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research Department of Neuroradiopharmaceuticals Leipzig Germany.ORCID 0000-0001-9743-2325
Magali ToussaintHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research Department of Neuroradiopharmaceuticals Leipzig Germany.ORCID 0000-0002-1136-3857
Peter BrustHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research Department of Neuroradiopharmaceuticals Leipzig Germany.ORCID 0000-0001-5555-7058
Torsten KniessHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research Department of Radiopharmaceutical and Chemical Biology Dresden Germany.ORCID 0000-0002-4107-3455
Anja OelschlegelLeibniz-Institute for Neurobiology Magdeburg Germany.
Jürgen GoldschmidtLeibniz-Institute for Neurobiology Magdeburg Germany.
Sven MeuthDepartment of Neurology Heinrich-Heine-University Düsseldorf Germany.ORCID 0000-0003-2571-3501
Patrick MüllerDepartment of Cardiology Otto-von-Guericke University Magdeburg Germany.
Rüdiger Braun-DullaeusDepartment of Cardiology Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0003-3888-6532
Grazyna Debska-VielhaberDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0002-6661-9821
Stefan VielhaberDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.
Axel BeckerInstitute of Pharmacology and Toxicology Otto-von-Guericke University Magdeburg Germany.
Alexander DityatevGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association Magdeburg Germany.ORCID 0000-0002-0472-0553
Solveig HenneickeDepartment of Neurology Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0002-9103-7276
Michael Sendtner *Institute of Clinical Neurobiology University Hospital Würzburg Würzburg Germany.ORCID 0000-0002-4737-2974
Ildiko Dunay *Institute of Inflammation and Neurodegeneration Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0002-9900-8605
Stefanie Schreiber *Department of Neurology Otto-von-Guericke University Magdeburg Germany.ORCID 0000-0003-4439-4374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic arterial hypertension causes cerebral microvascular dysfunction and increases dementia risk in aging. However, cognitive health preservation by therapeutic blood pressure lowering alone is limited and depends on disease duration, the degree of irreversible tissue damage, and whether microvascular function can be restored. This study aimed to understand molecular and cellular temporospatial mechanisms of disease in the course of hypertension.

methodsWe investigated the effects of initial, early chronic and late chronic hypertension in the frontal brain of spontaneously hypertensive stroke-prone rats by applying behavioral tests, histopathology, immunofluorescence, fluorescence-activated cell sorting, microvascular/neural tissue RNA sequencing, and

resultsChronic hypertension caused behavioral deficits associated with frontal cortex function. Our results highlight stage-dependent responses to continuous microvascular stress and wounding by hypertension. Early chronic responses included a fast recruitment of activated microglia to the blood vessels, immigration of peripheral immune cells, blood-brain barrier breakdown and an energy-demanding hypermetabolic state. Vascular adaptation mechanisms were observed in later stages and included angiogenesis and upregulation of cellular adhesion molecules and extracellular matrix. Among the top upregulated genes in blood vessels, we identified

conclusionsOur study provides new insight into mechanisms underlying hypertensive pathobiology and highlights its stage-dependent nature. This groundwork will be helpful for basic and clinical research to identify stage-dependent markers in the human disease course, investigate stage-dependent interventions besides blood pressure lowering, and better understand the relationship between poor vascular health and neurodegenerative diseases.

Indexed as

Cognitive DysfunctionFrontal LobeHypertensionInflammationTranscriptomeAnimalsBehavior, AnimalBlood-Brain BarrierBlood PressureDisease Models, AnimalMaleMicrogliaRatsRats, Inbred SHR18F‐FDG PETcerebral small‐vessel diseasehypertensionRNA sequencingSHRSP

Identifiers

PMID41294147
PMCPMC13055842

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.